Abstract
The initial phase of septic shock is characterized by a generalized production of proinflammatory humoral mediators, which belong to the cytokine network, complement-system, contact- and fibrinolytic system. At the same time there is activation of neutrophils, mononuclear cells, endothelial cells, and other cells of the host defense system.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Waage A, Halstensen A, Espevik T (1987) Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet I: 355–357
Girardin E, Grau GE, Dayer J-M, et al and the J5 Study Group (1988) Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Eng J Med 319: 397–400
Calandra T, Baumgartner J-D, Grau GE, et al (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-a, and interferon-i in the serum of patients with septic shock. J Infect Dis 161: 982–987
Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771–778
Engelberts I, Stephens S, Francot GJM, van der Linden CJ, Buurman WA (1991) Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338: 515–516
Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA (1993) Measuring cytokines. J Appl Physiol 75: 1897–1902
Raqib R, Lindberg AA, Wretland B, Bardhan PK, Andersson U, Andersson J (1995) Persistence of local cytokine production in shigellosis in acute and convalescent stages. Infect Immun 63: 289–296
Marks JD, Marks CB, Luce JM, et al (1990) Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration. Am Rev Respir Dis 141: 94–97
Kornelisse RF, Hazelzet JA, Savelkoul HFJ, et al (1996) The relationship between plasminogen activator inhibitor-1 and pro-inflammatory and counter-inflammatory mediators in children with meningococcal septic shock. J Infect Dis 173: 1148–1156
Waage A, Aasen AO (1992) Different role of tumor necrosis factor in septic shock in relation to meningococcal disease and surgery/polytrauma. Immunol Rev 127: 221–230
Granowitz EV, Santos AA, Poutsiaka DD, et al (1991) Production of interleukin- 1-receptor antagonist during experimental endotoxaemia. Lancet 338: 1423–1424
Kuhns DB, Alvord WG, Gallin J (1995) Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 171: 145–152
Rogy MA, Coyle SM, Oldenburg HS, et al (1994) Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J Am Coll Surg 178: 132–138
Van Deuren M, Van der Ven-Jongekrijg J, Bartelink AKM, Van Dalen R, Sauerwein RW, Van der Meer JWM (1995) Correlation between pro-inflammatory cytokines and anti-inflammatory mediators and the severity of disease in meningococcal infections. J Infect Dis 172: 433–439
Smith RA, Baglioni C (1987) The active form of tumor necrosis factor is a trimer. J Biol Chem 262: 6951–6954
Olsson I, Gatanaga T, Gullberg U, Lantz M, Granger GA (1993) Tumour necrosis factor ( TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw 4: 169–180
Tennesen E, Hansen MB, Höhndorf K, et al (1993) Cytokines in plasma and ultrafiltrate during continuous arteriovenous haemofiltration. Anesth Intensive Care 21: 752–758
Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21: 522–526
Goldfarb S, Golper TA (1994) Proinflammatory cytokines and hemofiltration membrane. J Am Soc Nephrol 5: 228–232
Bellomo R, Tipping P, Boyce N (1995) Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 17: 457–466
Best C, Walsh J, Sinclair J, Beattle J (1996) Early haemo-diafiltration in meningococcal septicaemia. Lancet 347: 202–205
Chapman PB, Lester TJ, Casper ES, et al (1987) Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncology 5: 1942–1951
Blick M, Sherwin SA, Rosenblum M, Guttermen J (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47: 2986–2989
Gamm H, Lindemann A, Mertelsmann R, Herrmann F (1991) Phase I trial of recombinant human tumor necrosis factor alpha in patients with advanced malignancy. Eur J Cancer 27: 856–863
Poole S, Bird TA, Selkirk S, et al (1990) Fate of injected interleukin 1 in rats: Sequestration and degradation in the kidney. Cytokine 2: 416–422
Reimers J, Wogensen LD, Welinder B, et al (1991) The pharmacokinetics, distribution and degradation of human recombinant interleukin 1 beta in rats. Scan J Immunol 34: 597–610
Gray JE, Peterman V, Neweton R, King SY, Pieniaszek HJ Jr (1993) ELISA determination and preliminary pharmacokinetics of modified rIL-1 beta in dogs. Res Commun Chem Pathol Pharmacol 81: 233–241
Nerad JL, Griffiths JK, Van der Meer JWM, et al (1992) Interleukin-lß (IL-1ß), IL-1 receptor antagonist, and TNF-a production in whole blood. J Leukocyte Biol 52: 687–692
Van Deuren M, Van der Ven-Jongekrijg J, Keuter M, Demacker PNM, Van der Meer JWM (1993) Cytokine production in whole blood cultures. J Int Fed Clin Chem 5: 216–221
Netea MG, Drenth JPH, De Bont N, et al (1997) A quantitative reverse transcriptase polymerase chain reaction method for measurement of mRNA tor TNF-a and IL-1ß in whole blood cultures. Cytokine (In press)
Van Deuren M, Van der Ven-Jongekrijg J, Demacker PNM, et al (1994) Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 169: 157–161
Granowitz EV, Porat R, Mier JW, et al (1993) Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J Immunol 151: 1637–1645
Ertel W, Kremer JP, Kenney J, et al (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85: 1341–1347
Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P (1995) Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense? Intensive Care Med 21: 169–176
Staubauch KH, Rau HG, Kooistra A, Shardey HM, Hohlbach G, Schildberg FW (1989) Can hemofiltration increase survival in acute endotoxemia–A porcine shock model. Prog Clin Biol Res 308: 821–826
Stein B, Pfenninger E, Grunert A, Schmitz JE, Hudde M (1990) Influence of continuous haemofiltration on haemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 16: 494–499
Gomez A, Wang R, Unruh H, et al (1990) Hemofiltration reverses left ventricular dysfunction in dogs. Anesthesiology 73: 671–685
Stein B, Pfenninger E, Grünert A, Schmitz JE, Deller A, Kocher F (1991) The consequences of continuous hemofiltration on lung mechanics and extravascular lung water in a porcine endotoxic shock model. Intensive Care Med 17: 293–298
Grootendorst AF, Van Bommel EFH, Van der Hoven B, Van Leengoed LA, Van Osta ALM (1992) High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18: 235–240
Lee PA, Matson JR, Pryor RW, Hinshaw LB (1993) Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicaemia in immature swine. Crit Care Med 21: 914–924
Freeman BD, Yatsiv I, Natanson C, et al (1994) Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 180: 286–292
Kumar A, Thota V, Dee L, Olson J, Uretz E, Parillo JE (1996) Tumor necrosis factor-a and interleukin-1 ß are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183: 949–958
Byrick RJ, Goldstein MB, Wong PY (1992) Increased plasma tumor necrosis factor concentration in severe rhabdomyolysis is not reduced by continuous arterioveneous hemodialysis. Crit Care Med 20: 1483–1486
Reeves JH, Butt WW (1995) Blood filtration in children with severe sepsis: Safe adjunctive therapy. Intensive Care Med 21: 500–504
Barrera P, Janssen EM, Demacker PNM, Wetzels JFM, Van der Meer JWM (1992) Removal of interleukin-1(3 and tumor necrosis factor from human plasma by in vitro dialysis with poly-acrylonitrile membranes. Lymphokine Cytokine Res 11: 99–104
Vain NE, Mazlumian, Swarner W, Cha CC (1980) Role of exchange transfusion in the treatment of severe septicaemia. Pediatrics 66: 693–697
Togari H, Mikawa M, Iwanaga T, et al (1983) Endotoxin clearance by exchange blood transfusion in septic shock neonates. Acta Paediatr Scand 72: 87–91
Muraji T, Okamoto E, Hogue S, Toyosaka A (1986) Plasma exchange therapy for endotoxin shock in puppies. J Pediatr Surg 21: 1092–1095
Natanson C, Hoffman WD, Danner RL, et al (1989) A controlled trial of plasmapheresis fails to improve outcome in an antibiotic treated canine model of septic shock. Crit Care Med 17: S57 (Abst)
Rokke 0, Lundgren TI, Revhaug A, Giercksky KE, f sterud B, Rekvig OP (1989) Plasma exchange performed during severe Gram-negative septicemia: The influence on circulatory performance, plasma levels of endotoxin and bacterial counts in blood. Surg Res Comm 5: 59–73
Rokke O, Rasmussen L, Giercksky KE, Seljelid R, Rekvig OP, Revhaug A (1990) The influence of plasma exchange on shock mediators in septicemia. Surg Res Comm 8: 173–182
Rokke O, Rekvig OP, Revhaug A (1990) Continuous removal of leucocytes during early Gram-negative septicemia reduces plasma levels of endotoxin and improves cardiac performance. Scand J Infect Dis 22: 79–86
Rokke O, Rekvig OP, Lundgren TI, Revhaug A (1990) The treatment of severe Gram-negative septicemia with plasma exchange: Effects mediated by extracorporal circulation. Surg Res Comm 8: 183–194
Busund R, Lindsetmo RO, Rasmussen LT, Rokke O, Rekvig OP, Revhaug A (1991) Tumor necrosis factor and interleukin-1 appearance in experimental Gram-negative septic shock. Arch Surg 126: 591–597
Rokke O, Rolf S, Revhaug A, Rekvig OP (1993) Plasma exchange, but not extra-corporeal recirculation nor removal of white blood cells, depresses plasma levels of IL-1 during severe Gram-negative septicemia. Transfus Sci 14: 173–182
Scharfman WB, Tillotson JR, Taft EG, Wright E (1979) Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med 300: 1277–1280
Bjorvatn B, Bjertnaes L, Fadnes HO, et al (1984) Meningococal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J 288: 439–441
Osterud B (1985) Meningococcal septicemia: The use of plasmapheresis or blood exchange and how to detect severe endotoxin white cell activation. Scand J Clin Lab Invest 45 (Suppl 178): 47–51
Brandtzaeg P, Sirnes K, Folsland B, et al (1985) Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients. Scand J Clin Lab Invest 45 (Suppl 178): 53–55
Vesely H, Mauritz W, Ammann G, Herold S, Marczell A (1987) Plasma exchange in a patient with acute abdomen complicated by multiple organ failure. Anaesth Intensivther Notfallmed 22: 198–200
Drapkin MS, Wisch JS, Gelfand JA, Cannon JG, Dinarello CA (1989) Plasmapheresis for fulminant meningococcemia. Pediatr Infect Dis J 6: 399–400
Janbon B, Vuillez J-P, Carpentier F, et al (1992) Removal of circulating tumor necrosis factor. Its role in septic shock treatment. Ann Intern Med 143 (Suppl 1): 13–16
Westendorp RGJ, Brand A, Haanen J, et al (1992) Leukaplasmapheresis in meningococcal septic shock. Am J Med 92: 577–578
Van Deuren M, Santman FW, Van Dalen R, et al (1992) Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis 15: 424–430
Pollack M (1992) Blood exchange and plasmapheresis in sepsis and septic shock. Clin Infect Dis 15: 431–433
Gârdlund B, Sjölin J, Nilsson A, et al (1993) Plasmapheresis in the treatment of primary septic shock in humans. Scand J Infect Dis 25: 757–761
Mok Q, Butt W (1996) The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med 22: 259–263
Cohen J, Aslam M, Pusey CD, Ryan CJ (1987) Protection from endotoxemia: A rat model of plasmapheresis and specific adsorbtion with polymyxin B. J Intect Dis 155: 690–695
Frieling JTM, Van Deuren M, Wijdenes J, Sauerwein R, Van der Linden CJ (1997) Patterns of interleukin-6 and its soluble receptor during acute meningococcal infections and the effect of plasma or whole blood exchange. Crit Care Med (In press)
Schedel I, Dreikhausen U, Nentwig B, et al (1991) Treatment of Gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial. Crit Care Med 19: 1104–1113
Brandtzaeg P, Sandset PM, Joo GB, Ovstebo R, Abildgaard U, Kierulf P (1989) The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Tromb Res 55: 459–470
Leclerc F, Hazelhet J, Jude B, et al (1992) Protein C and S deficiency in severe infectious purpura of children: A collaborative study of 40 cases. Intensive Care Med 18: 202–205
Fijnvandraat K, Derkx HHF, Peters M, et al (1995) Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality. Thromb Haemost 73: 15–20
Rivard GE, David M, Farell C, Schwarz P (1995) Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 126: 646–652
Von Uppenkamp M, Hoensch HP, Lögering HJ, Paar D, Ohnhaus EE (1986) Antithrombin-III Substitution bei akuter bakterieller Meningitis. Fortschr Med 104: 121–125
Nuijens JH, Eerenberg-Belmer AJM, Huijbregts CCM, et al (1989) Proteolytic inactivation of plasma Cl inhibitor in sepsis. J Clin Invest 84: 443–450
Schott U, Bjorsell-Ostling E (1995) Sonoclot coagulation analysis and plasma exchange in a case of meningococcal septicaemia. Can J Anaesth 42: 64–68
Fourrier F, Jourdain M, Tournois A, Caron C, Goudemand J, Chopin C (1995) Coagulation inhibitor substitution during sepsis. Intensive Care Med 21: S264 - S268
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
van Deuren, M., van der Meer, J.W. (1997). Extracorporal Techniques to Accelerate Clearance of TNF-α and IL-1β in Septic Patients. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1997. Yearbook of Intensive Care and Emergency Medicine, vol 1997. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13450-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-662-13450-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-13452-8
Online ISBN: 978-3-662-13450-4
eBook Packages: Springer Book Archive